PedAM
Pediatric Disease Annotations & Medicines
| Disease | portal hypertension |
| Phenotype | C0023895|liver disease |
| Sentences | 47 |
| PubMedID- 22610002 | Background & aims: little is known about the prevalence and severity of portal hypertension in patients with nonalcoholic fatty liver disease (nafld). |
| PubMedID- 21712949 | Further evaluation showed that he had chronic liver disease with portal hypertension and was hepatitis b surface antigen-positive, indicating hepatitis b infection. |
| PubMedID- 22190914 | Reported that the accuracy of their string ece for diagnosing ev and portal hypertension in patients with chronic liver disease was excellent [23]. |
| PubMedID- 22662598 | Clinical application of transient elastography in prediction of portal hypertension related complication in patients with chronic liver diseases. |
| PubMedID- 24142390 | The insertion of a transjugular intrahepatic portosystemic shunt (tips) is a minimally invasive procedure used to relieve the signs and symptoms of portal hypertension in patients with liver disease. |
| PubMedID- 21196656 | Esophageal varices develop as a consequence of portal hypertension in patients with chronic liver disease and are present in approximately 50% of patients with cirrhosis of the liver. |
| PubMedID- 21978390 | Markers of impaired intestinal permeability are elevated in portal hypertension, particularly with severe liver disease, and in viral and alcoholic cirrhosis [11,32]. |
| PubMedID- 25568485 | However, ultrasound examination of the abdomen revealed parenchymal liver disease with portal hypertension and ascites. |
| PubMedID- 23123767 | Measuring spp using ultrasound is most simple and minimally invasive, and it might be useful for evaluating portal hypertension in dogs with liver diseases. |
| PubMedID- 22973991 | Objectives: transient elastography (te), as a non-invasive method, has been studied for evaluation of portal hypertension in patients with chronic liver diseases (cld) with variable results. |
| PubMedID- 23343370 | Among them there was only one patient who developed severe liver disease with portal hypertension. |
| PubMedID- 21685145 | Background: a group of non-cirrhotic chronic liver diseases, all with sustained portal hypertension and clinically mistaken as cirrhosis, have been described under various names, apparently because of differences in pathological features. |
| PubMedID- 24613858 | Purpose of review: cirrhosis is the result of the progression of necroinflammatory liver diseases leading to fibrosis, portal hypertension, and a catabolic state, which might cause muscle wasting or sarcopenia. |
| PubMedID- 22623827 | He was a known case of alcoholic liver disease with portal hypertension categorised as child's class a. there was no visible caput medusae or audible periumbilical venous hum. |
| PubMedID- 24616589 | Relationship between tetrahydrobiopterin and portal hypertension in patients with chronic liver disease. |
| PubMedID- 24782928 | Dyspnea in a patient with liver dysfunction usually makes one suspects hepatopulmonary syndrome, portopulmonary hypertension, cardiomyopathy, hepatic hydrothorax, ascites, or anemia, whereas ascites itself is a hallmark of liver disease complicated by portal hypertension. |
| PubMedID- 22986694 | Purpose: cystic-fibrosis-associated liver disease (cfld) may lead to portal hypertension (pht) and cirrhosis. |
| PubMedID- 25667596 | Cirrhosis is scarring of the liver and also is the final stage of many chronic liver diseases, leading to portal hypertension and end-stage liver disease [1]. |
| PubMedID- 23812037 | Therefore, hscs can contribute to portal hypertension in patients with chronic liver disease (cld). |
| PubMedID- 25147571 | The most common cause of colonic varices is portal hypertension associated with liver disease or secondary to pancreatic conditions, like chronic pancreatitis or malignancies. |
| PubMedID- 26297362 | Bacterial infections are an important cause of morbidity and mortality in patients with lc due to an impaired immune function, together with an increased passage of bacteria from the gut (bacterial translocation).4521 once infection occurs, it may lead to sirs, which can cause serious complications such as severe sepsis, renal dysfunction, encephalopathy, coagulopathy and multiple organ failure.21 sirs occurs more frequently in patients with advanced cirrhosis and portal hypertension, and is associated with severity of liver disease and increased risk of death in patients with lc.45 the mortality of patients with lc with infection has been reported to be more than twice that of patients without infection.21 monocytes are central mediators of the immune response and play a crucial role in the pathogenesis of lc. |
| PubMedID- 22586877 | She also had diagnoses of chronic liver disease with cirrhotic changes, portal hypertension, and grade iv manageesophageal varices with hepatosplenomegaly. |
| PubMedID- 21813019 | To our knowledge, ha is the only serum marker that has been confirmed as an independent predictor of portal hypertension in patients with liver disease [20]. |
| PubMedID- 25374709 | Hepatic myelopathy or porto-systemic myelopathy is a rare neurological complication of chronic liver disease with portal hypertension, usually associated with porto-systemic shunting, and presents as pure motor spastic paraparesis without sensory or sphincter involvement. |
| PubMedID- 23610585 | Lack of hepatic clearance of these components from circulation is enhanced due to portal hypertension in liver disease. |
| PubMedID- 22689731 | Here, the authors discuss a case of pancreatic ascites developing in the setting of alcoholic liver disease with portal hypertension. |
| PubMedID- 25590846 | Furthermore, to exclude the effect of cardiovascular factors, patients with confirmed cardiovascular diseases or taking any agents affecting qtc interval before the establishment of achblf were excluded, such as β-blockers, even if it is recommended in patients with portal hypertension associated with chronic liver diseases. |
| PubMedID- 21055685 | Hepatic granulomas may be manifested clinically by elevated levels of serum alkaline phosphatase and g-glutamyltransferase enzymes, damage to specific structures (eg, intrahepatic bile ducts in primary biliary cirrhosis), or infrequently, progressive liver disease with portal hypertension and cirrhosis (eg, sarcoidosis). |
| PubMedID- 21932390 | Targeting angiogenesis in chronic liver diseases with portal hypertension: anti-placenta growth factor inhibitor or multikinase inhibitor sorafenib. |
| PubMedID- PMC3239438 | The patient was suffering from advanced liver disease with portal hypertension and multiple current inter abdominal abscesses. |
| PubMedID- 20453271 | A novel mutation g-to-a at position 333 in exon v was found in two siblings having positive immunohistochemistry for aat on liver biopsy, both of whom had significant liver disease with portal hypertension. |
| PubMedID- 24714325 | As the patient has chronic liver disease along with portal hypertension, he has been referred for work up for liver transplantation. |
| PubMedID- 21389796 | Noncirrhotic human nonalcoholic fatty liver disease induces portal hypertension in relation to the histological degree of steatosis. |
| PubMedID- 26117383 | Severe mdr3 deficiency typically presents during the first year of life or early childhood, often progressing to chronic liver disease with cirrhosis and portal hypertension, requiring liver transplantation. |
| PubMedID- 24759352 | The patient was diagnosed as having chronic liver disease with portal hypertension, with etiology probably related to non-alcoholic steatohepatitis (nash), with present decompensation due to drug-induced liver injury and sbp due to s. typhimurium. |
| PubMedID- 21229317 | Unfortunately, the patient had progressive biliary cirrhosis to end-stage liver disease complicated with portal hypertension for which she underwent successful orthotopic liver transplant at 7 years of age. |
| PubMedID- 24457056 | Aitp has been classified either as a primary autoimmune disorder or as secondary to a number of underlying conditions such as lymphoproliferative disorders, myelodysplasia, autoimmune collagen vascular diseases (e.g., systemic lupus erythematosus, antiphospholipid antibody syndrome) liver disease with portal hypertension, drugs or viral infection. |
| PubMedID- 24796378 | Aim: liver fibrosis occurs as a result of several chronic liver diseases and leads to portal hypertension, cirrhosis and liver failure, often requiring liver transplantation. |
| PubMedID- 26201624 | Hepatic hydrothorax (hh) is an infrequent but a well-known complication of portal hypertension in patients with end-stage liver disease. |
| PubMedID- 22270437 | Background: cirrhotic liver disease commonly is complicated by portal hypertension, and the resultant porto-systemic shunts are an important cause of morbidity and mortality in cirrhotic patients. |
| PubMedID- 20065573 | Background/aim: esophageal varices (evs) are a serious consequence of portal hypertension in patients with liver diseases. |
| PubMedID- 24771990 | Chronic liver disease, especially with associated portal hypertension, has also been linked to the presence of gi angioectasias and, as reported by some authors, they could be reversed after transjugular intrahepatic portosystemic shunt [34, 38, 39]. |
| PubMedID- 24340101 | Two weeks after the surgery [28], the animal model of obstructive liver disease with portal hypertension was developed. |
| PubMedID- 24171010 | The authors concluded that patients who carry the z allele are at greater risk (or, ≈ 5) of developing severe liver disease with portal hypertension (31). |
| PubMedID- 23671546 | Exclusionary criteria were contraindications to wbv [43], severe cf (forced expiratory volume in 1 minute (fev1 < 40% predicted)), inability to stand unaided for 30 minutes, long bone or vertebral fracture in the past six months, past/present history of osteoarthritis, presence of cf-liver disease with portal hypertension, neuropathy or myopathy and/or vitamin d deficiency (25-hydroxyvitamin d < 39 nmol/l) in the past three months. |
| PubMedID- 24820314 | Hps is a significant complication of portal hypertension in children with chronic liver disease and is an established indication for lt. |
| PubMedID- 22567478 | Significant morbidity is seen in those patients who develop complications such as end-stage renal diseases, chronic liver diseases with portal hypertension, and cancers associated with schistosomiasis [1–3]. |
Page: 1